Digestive system

FDA Grants Rafael Pharmaceuticals Orphan Drug Designation for CPI-613® (Devimistat) for Treatment of Biliary Cancer

Retrieved on: 
Tuesday, June 29, 2021

CRANBURY, N.J., June 29, 2021 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (Rafael or the Company), a leader in the growing field of cancer metabolism-based therapeutics, announced today that the U.S. Food and Drug Administration (FDA) granted orphan drug designation for CPI-613 (devimistat) for the treatment of biliary cancer.

Key Points: 
  • CRANBURY, N.J., June 29, 2021 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc. (Rafael or the Company), a leader in the growing field of cancer metabolism-based therapeutics, announced today that the U.S. Food and Drug Administration (FDA) granted orphan drug designation for CPI-613 (devimistat) for the treatment of biliary cancer.
  • Biliary cancer appears when cancer cells form in the bile ducts or gallbladder, an essential aspect of the gastrointestinal system.
  • The orphan drug designation for devimistat showcases the importance of discovering these new treatment options.
  • Devimistat has been granted orphan drug status by the FDA for the treatment of pancreatic cancer, acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), Burkitts lymphoma, peripheral T-cell lymphomas, and soft tissue sarcoma, and now, biliary cancer.

Global Probiotic Ingredients Market (2021 to 2026) - Growth, Trends, COVID-19 Impact and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Friday, June 25, 2021

The demand for probiotic ingredients is primarily driven by increasing application in nutraceuticals, such as fortified food and beverage products, and dietary supplements.

Key Points: 
  • The demand for probiotic ingredients is primarily driven by increasing application in nutraceuticals, such as fortified food and beverage products, and dietary supplements.
  • It can also be concluded that young Americans do not want to suffer at an old age, unlike their elders.
  • For instance, Probi, a global probiotic solution company, signed a distribution agreement with Laboratorio Daudt (a Brazilian pharmaceutical company).
  • Under the agreement, Daudt agreed to launch the probiotic supplement, Probi Mage, in the Brazilian market.

Avalife's Probiotics Are Friendly Visitors

Retrieved on: 
Friday, June 25, 2021

The trillions of friendly microbes that live in the gut also produce chemical reactions that affect how the brain works.

Key Points: 
  • The trillions of friendly microbes that live in the gut also produce chemical reactions that affect how the brain works.
  • Probiotics have long been pursued as a natural way to enhance gut health and keep one's intestinal flora balanced.
  • As the health and wellness experts at the supplement brand Avalife explain, "Probiotics are only 'visitors' in your intestine and will disappear along with their health benefits if not consumed regularly."
  • Ultra-Balance: The 50 Billion CFU, 6 Strain combination of probiotics is exclusively formulated for maximum support of the gut microbiome.

TCI JAPAN Launched its Breakthrough, SCIENCE OF PROBIOTICS, Demonstrating How to Keep Probiotics Alive without Refrigeration for over 1 year

Retrieved on: 
Friday, June 25, 2021

Among all commercially available probiotics, lactic acid bacteria are the most widely known to consumers.

Key Points: 
  • Among all commercially available probiotics, lactic acid bacteria are the most widely known to consumers.
  • Lactic acid bacteria refer to a group of bacteria that can convert sugars, such as glucose and lactose, into lactic acid by fermentation.
  • In Japan, lactic acid bacteria have been consumed for a diverse range of health benefits for years.
  • According to research, it is by colonizing the intestinal tract that lactic acid bacteria can exert their effect on intestinal regulation.

Native Microbials Introduces Arkus™ Daily to Support Dog Health from the Inside Out

Retrieved on: 
Thursday, June 24, 2021

Native Microbials , a biotechnology company with a focus on animal health and nutrition, recently launched Arkus Daily as a unique offering in the dog supplement space.

Key Points: 
  • Native Microbials , a biotechnology company with a focus on animal health and nutrition, recently launched Arkus Daily as a unique offering in the dog supplement space.
  • We are excited to launch Arkus Daily to help promote digestive health in dogs using our proprietary scientific approach, said Mallory Embree, chief science officer at Native Microbials.
  • Arkus Daily is the result of significant research to determine the ideal canine microorganisms that support better digestion and a strong immune system, among other benefits.
  • Native Microbials harnesses the power of the native microbiome to improve animal health, productivity and sustainability.

Albireo to Present at Piper Sandler’s Virtual EASL Takeaway Day

Retrieved on: 
Thursday, June 24, 2021

BOSTON, June 24, 2021 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile acid modulators, today announced thatRon Cooper, President and Chief Executive Officer, will present as part of a fireside chat at Piper Sandlers Virtual EASL Takeaway Day on Monday, June 28, at10:00 a.m. EDT.

Key Points: 
  • BOSTON, June 24, 2021 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq: ALBO), a rare liver disease company developing novel bile acid modulators, today announced thatRon Cooper, President and Chief Executive Officer, will present as part of a fireside chat at Piper Sandlers Virtual EASL Takeaway Day on Monday, June 28, at10:00 a.m. EDT.
  • Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases.
  • Albireo was spun out from AstraZeneca in 2008 and is headquartered in Boston, Massachusetts, with its key operating subsidiary in Gothenburg, Sweden.
  • The Boston Business Journal named Albireo one of the 2020 Best Places to Work in Massachusetts for the second consecutive year.

Mia Syn, RDN Partners with Digestive Health Company PanTheryx

Retrieved on: 
Wednesday, June 23, 2021

PanTheryx, an integrative digestive and immune health company, today announced its partnership with Mia Syn, MS, RDN as the companys new nutrition advisor for its TruBiotics brand of probiotics and its Lifes First Naturals brand of colostrum based dietary supplements.

Key Points: 
  • PanTheryx, an integrative digestive and immune health company, today announced its partnership with Mia Syn, MS, RDN as the companys new nutrition advisor for its TruBiotics brand of probiotics and its Lifes First Naturals brand of colostrum based dietary supplements.
  • We are pleased to have Mia Syn join our effort in growing awareness of the numerous digestive and immune health benefits of probiotics and colostrum among health-conscious adults, said Wes Parris, president and CEO, PanTheryx.
  • TruBiotics is a high-quality probiotic supplement that works naturally to support digestive and immune health in adults.
  • PanTheryx is a nutrition and biotechnology company committed to the broad commercialization of health and wellness solutions for the global human and animal health markets.

Micro-Tech Endoscopy Announces the Release of its New Submucosal Lifting Agent

Retrieved on: 
Tuesday, June 22, 2021

ANN ARBOR, Mich., June 22, 2021 /PRNewswire/ -- Micro-Tech Endoscopy recently expanded its EMR and ESD portfolio with the launch of its BlueBoost submucosal lift.

Key Points: 
  • ANN ARBOR, Mich., June 22, 2021 /PRNewswire/ -- Micro-Tech Endoscopy recently expanded its EMR and ESD portfolio with the launch of its BlueBoost submucosal lift.
  • BlueBoost is a viscous submucosal injection fluid designed to increase the efficiency of resection procedures.
  • Lifts and separates the gastrointestinal mucosa from the submucosal layer to help identify the margin around the lesion.
  • Micro-Tech Endoscopy has operations in America, Asia, and Europe and leverages this global reach to refine the products the company provides to partners.

Global Prebiotic Ingredients Market (2021 to 2026) - Growth, Trends, COVID-19 Impact and Forecasts - ResearchAndMarkets.com

Retrieved on: 
Monday, June 21, 2021

Moreover, key players are also actively offering prebiotic supplements, as maintenance of a healthy gut is increasingly becoming important among consumers.

Key Points: 
  • Moreover, key players are also actively offering prebiotic supplements, as maintenance of a healthy gut is increasingly becoming important among consumers.
  • According to the international study by Beneo Inc., 42% of consumers are very or extremely interested in gut microbiome.
  • Such factors are escalating the application of prebiotic ingredients in various food and beverage applications.
  • Healthcare professionals across the region recommend dietary supplements containing prebiotic ingredients to their patients, to combat health challenges.

KeVita and Amber Riley Team Up to Celebrate the Summer of Self-Care with New Prebiotic Shots

Retrieved on: 
Tuesday, June 22, 2021

"I've been a long-time fan of KeVita, especially their Lemon Ginger Sparkling Probiotic Drink, so I was excited to be one of the first to try the new Prebiotic Shots line.

Key Points: 
  • "I've been a long-time fan of KeVita, especially their Lemon Ginger Sparkling Probiotic Drink, so I was excited to be one of the first to try the new Prebiotic Shots line.
  • Between filming, working out and spending time with my family and friends, these convenient shots fit perfectly into my schedule.
  • KeVita's organic Prebiotic Shots are fermented with water kefir culture and offer three grams of prebiotic fiber.
  • KeVita Prebiotic Shots begin to roll out this summer at mass grocery, drug, convenience and specialty food stores nationwide.